Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/94757
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLau, D.-
dc.contributor.authorKalman, J.-
dc.contributor.authorSanders, P.-
dc.date.issued2014-
dc.identifier.citationClinical Therapeutics: the international peer-reviewed journal of drug therapy, 2014; 36(9):1151-1159-
dc.identifier.issn0149-2918-
dc.identifier.issn1879-114X-
dc.identifier.urihttp://hdl.handle.net/2440/94757-
dc.description.abstractAbstract not available-
dc.description.statementofresponsibilityDennis H.Lau, Jonathan Kalman, Prashanthan Sanders-
dc.language.isoen-
dc.publisherElsevier-
dc.rights© 2014 Published by Elsevier HS Journals, Inc.-
dc.source.urihttp://dx.doi.org/10.1016/j.clinthera.2014.08.002-
dc.subjectantiarrhythmic drugs-
dc.subjectanticoagulation-
dc.subjectatrial fibrillation-
dc.subjectelectrical cardioversion-
dc.titleManagement of recent-onset sustained atrial fibrillation: pharmacologic and nonpharmacologic strategies-
dc.typeJournal article-
dc.identifier.doi10.1016/j.clinthera.2014.08.002-
pubs.publication-statusPublished-
dc.identifier.orcidLau, D. [0000-0001-7753-1318]-
dc.identifier.orcidSanders, P. [0000-0003-3803-8429]-
Appears in Collections:Aurora harvest 3
Medicine publications

Files in This Item:
File Description SizeFormat 
hdl_94757.pdfAccepted version213.01 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.